The diarylsulfonylurea-containing compound, MCC950, is a specific inhibitor of NLRP3 inflammasome activation that abrogates ASC oligomerization in human macrophages and in in vivo models of multiple sclerosis and Parkinson ́s disease [16,17]. The gene discussed is NLRP3; the disease is Parkinson disease.